<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Inflamed Skin Conditions - Clinical Decision Support</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
            padding: 20px;
            line-height: 1.6;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            position: relative;
        }

        .header {
            text-align: center;
            color: white;
            margin-bottom: 30px;
        }

        .header h1 {
            font-size: 2.5em;
            margin-bottom: 10px;
            text-shadow: 2px 2px 4px rgba(0,0,0,0.3);
        }

        .header p {
            font-size: 1.2em;
            opacity: 0.9;
        }

        .progress-sidebar {
            position: fixed;
            right: 20px;
            top: 50%;
            transform: translateY(-50%);
            background: white;
            border-radius: 15px;
            padding: 20px;
            box-shadow: 0 10px 30px rgba(0,0,0,0.2);
            z-index: 1000;
            min-width: 200px;
        }

        .progress-sidebar h3 {
            font-size: 1.1em;
            margin-bottom: 15px;
            color: #333;
            text-align: center;
        }

        .progress-item {
            display: flex;
            align-items: center;
            margin-bottom: 15px;
            padding: 10px;
            border-radius: 10px;
            cursor: pointer;
            transition: all 0.3s ease;
            opacity: 0.5;
        }

        .progress-item.active {
            opacity: 1;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
        }

        .progress-item.completed {
            opacity: 0.8;
            background: #e8f5e9;
        }

        .progress-item:hover {
            transform: translateX(-5px);
            box-shadow: 0 5px 15px rgba(0,0,0,0.1);
        }

        .progress-icon {
            width: 30px;
            height: 30px;
            margin-right: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 50%;
            font-size: 1.2em;
        }

        .progress-item.active .progress-icon {
            background: rgba(255,255,255,0.2);
        }

        .main-content {
            margin-right: 240px;
        }

        .step-card {
            background: white;
            border-radius: 20px;
            margin-bottom: 30px;
            box-shadow: 0 15px 35px rgba(0,0,0,0.1);
            overflow: hidden;
            transition: all 0.3s ease;
            border-left: 8px solid;
        }

        .step-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 20px 40px rgba(0,0,0,0.15);
        }

        .step-card.assessment {
            border-left-color: #667eea;
        }

        .step-card.diagnosis {
            border-left-color: #ff6b6b;
        }

        .step-card.treatment {
            border-left-color: #4ecdc4;
        }

        .step-card.followup {
            border-left-color: #45b7d1;
        }

        .card-header {
            padding: 25px;
            display: flex;
            align-items: center;
            cursor: pointer;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
        }

        .card-icon {
            width: 60px;
            height: 60px;
            border-radius: 15px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 2em;
            margin-right: 20px;
            color: white;
        }

        .assessment .card-icon {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
        }

        .diagnosis .card-icon {
            background: linear-gradient(135deg, #ff6b6b 0%, #ee5a24 100%);
        }

        .treatment .card-icon {
            background: linear-gradient(135deg, #4ecdc4 0%, #44a08d 100%);
        }

        .followup .card-icon {
            background: linear-gradient(135deg, #45b7d1 0%, #96c93d 100%);
        }

        .card-title {
            flex-grow: 1;
        }

        .card-title h2 {
            font-size: 1.8em;
            color: #333;
            margin-bottom: 5px;
        }

        .card-title p {
            color: #666;
            font-size: 1em;
        }

        .expand-icon {
            font-size: 1.5em;
            color: #666;
            transition: transform 0.3s ease;
        }

        .card-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease;
        }

        .card-content.expanded {
            max-height: 3000px;
        }

        .card-body {
            padding: 25px;
        }

        .section {
            margin-bottom: 25px;
            padding: 20px;
            background: #f8f9fa;
            border-radius: 10px;
            border-left: 4px solid #dee2e6;
        }

        .section h3 {
            color: #495057;
            margin-bottom: 15px;
            font-size: 1.3em;
            display: flex;
            align-items: center;
        }

        .section-icon {
            margin-right: 10px;
            font-size: 1.2em;
        }

        .badge {
            display: inline-block;
            padding: 5px 12px;
            border-radius: 20px;
            font-size: 0.85em;
            font-weight: bold;
            margin-left: 10px;
            text-transform: uppercase;
        }

        .badge.urgent {
            background: #dc3545;
            color: white;
        }

        .badge.caution {
            background: #ffc107;
            color: #212529;
        }

        .badge.stable {
            background: #28a745;
            color: white;
        }

        .conditions-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
            margin-top: 20px;
        }

        .condition-card {
            background: white;
            padding: 20px;
            border-radius: 10px;
            border: 2px solid #e9ecef;
            transition: all 0.3s ease;
        }

        .condition-card:hover {
            border-color: #667eea;
            box-shadow: 0 5px 15px rgba(102, 126, 234, 0.2);
        }

        .condition-card h4 {
            color: #495057;
            margin-bottom: 10px;
            font-size: 1.2em;
        }

        .treatment-step {
            background: white;
            padding: 15px;
            margin-bottom: 10px;
            border-radius: 8px;
            border-left: 4px solid #4ecdc4;
        }

        .treatment-step h5 {
            color: #495057;
            margin-bottom: 8px;
        }

        .treatment-step ul {
            margin-left: 20px;
            color: #6c757d;
        }

        .referral-criteria {
            background: #fff3cd;
            border: 1px solid #ffeaa7;
            border-radius: 10px;
            padding: 15px;
            margin-top: 15px;
        }

        .referral-criteria h4 {
            color: #856404;
            margin-bottom: 10px;
        }

        .important-note {
            background: #d1ecf1;
            border: 1px solid #bee5eb;
            border-radius: 10px;
            padding: 15px;
            margin: 15px 0;
        }

        .important-note h5 {
            color: #0c5460;
            margin-bottom: 8px;
        }

        @media (max-width: 768px) {
            .main-content {
                margin-right: 0;
            }
            
            .progress-sidebar {
                position: static;
                transform: none;
                margin-bottom: 20px;
                width: 100%;
            }
            
            .progress-item {
                display: inline-flex;
                margin-right: 10px;
                margin-bottom: 10px;
            }
            
            .header h1 {
                font-size: 2em;
            }
        }

        .fade-in {
            animation: fadeIn 0.5s ease;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .severity-indicators {
            display: flex;
            gap: 10px;
            margin: 20px 0;
            flex-wrap: wrap;
        }

        .severity-item {
            display: flex;
            align-items: center;
            padding: 10px 15px;
            background: white;
            border-radius: 8px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }

        .severity-dot {
            width: 12px;
            height: 12px;
            border-radius: 50%;
            margin-right: 8px;
        }

        .severity-dot.red { background: #dc3545; }
        .severity-dot.amber { background: #ffc107; }
        .severity-dot.green { background: #28a745; }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>ü©∫ Inflamed Skin Conditions</h1>
            <p>Clinical Decision Support Algorithm for Primary Care</p>
        </div>

        <div class="progress-sidebar">
            <h3>Progress</h3>
            <div class="progress-item active" data-step="assessment">
                <div class="progress-icon">üìã</div>
                <span>Assessment</span>
            </div>
            <div class="progress-item" data-step="diagnosis">
                <div class="progress-icon">üîç</div>
                <span>Diagnosis</span>
            </div>
            <div class="progress-item" data-step="treatment">
                <div class="progress-icon">üíä</div>
                <span>Treatment</span>
            </div>
            <div class="progress-item" data-step="followup">
                <div class="progress-icon">üìÖ</div>
                <span>Follow-up</span>
            </div>
        </div>

        <div class="main-content">
            <!-- Assessment Card -->
            <div class="step-card assessment fade-in">
                <div class="card-header" onclick="toggleCard(this)">
                    <div class="card-icon">üìã</div>
                    <div class="card-title">
                        <h2>Assessment</h2>
                        <p>Comprehensive history and examination of inflamed skin conditions</p>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-body">
                        <div class="section">
                            <h3><span class="section-icon">üìù</span>History Taking</h3>
                            <p><strong>Temporal Pattern & Triggers:</strong></p>
                            <ul style="margin-left: 20px; color: #6c757d;">
                                <li>Document onset, evolution, and duration</li>
                                <li>Precipitating factors (new products, exposures)</li>
                                <li>Current medications (many cause skin reactions)</li>
                                <li>Recent infections, psychological/social stressors</li>
                            </ul>
                            
                            <p style="margin-top: 15px;"><strong>Symptom Characterization:</strong></p>
                            <ul style="margin-left: 20px; color: #6c757d;">
                                <li><strong>Pruritus:</strong> Itch severity, impact on sleep</li>
                                <li><strong>Pain/Burning:</strong> Location and quality</li>
                                <li><strong>Systemic symptoms:</strong> Fever, malaise (red flag)</li>
                            </ul>

                            <p style="margin-top: 15px;"><strong>Personal & Environmental Factors:</strong></p>
                            <ul style="margin-left: 20px; color: #6c757d;">
                                <li>Family history of atopy (eczema, asthma, allergic rhinitis)</li>
                                <li>Occupational exposures (wet work, chemicals)</li>
                                <li>Hobbies, recent travel, pet exposure</li>
                                <li>Previous treatments and adherence</li>
                            </ul>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üî¨</span>Lesion Terminology</h3>
                            <div class="conditions-grid">
                                <div class="condition-card">
                                    <h4>üü§ Macule</h4>
                                    <p>Flat, colored lesion < 1cm</p>
                                </div>
                                <div class="condition-card">
                                    <h4>‚ö´ Papule</h4>
                                    <p>Elevated, solid lesion < 1cm</p>
                                </div>
                                <div class="condition-card">
                                    <h4>‚¨ú Plaque</h4>
                                    <p>Elevated, flat-topped > 1cm</p>
                                </div>
                                <div class="condition-card">
                                    <h4>üíß Vesicle</h4>
                                    <p>Fluid-filled lesion < 0.5cm</p>
                                </div>
                                <div class="condition-card">
                                    <h4>üî¥ Pustule</h4>
                                    <p>Pus-filled lesion</p>
                                </div>
                                <div class="condition-card">
                                    <h4>‚ö™ Nodule</h4>
                                    <p>Solid mass > 0.5cm</p>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üéØ</span>Distribution Patterns & Special Signs</h3>
                            <p><strong>Distribution:</strong> Flexural, extensor, acral (hands/feet), photodistributed</p>
                            <p><strong>Surface Changes:</strong> Scaly, crust, lichenified (thickened), excoriations (scratch marks)</p>
                            <p><strong>Configuration:</strong> Annular (ring-shaped), linear, follicular, dermatomal</p>
                            <p><strong>Special Signs:</strong></p>
                            <ul style="margin-left: 20px; color: #6c757d;">
                                <li><strong>Blanching vs Non-blanching:</strong> Press glass test</li>
                                <li><strong>Koebner phenomenon:</strong> Lesions appear at trauma sites</li>
                                <li><strong>Auspitz sign:</strong> Pinpoint bleeding after scale removal (psoriasis)</li>
                            </ul>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">‚ö†Ô∏è</span>Red Flags <span class="badge urgent">URGENT</span></h3>
                            <div class="referral-criteria">
                                <h4>Immediate Referral Indicators:</h4>
                                <ul style="margin-left: 20px; color: #856404;">
                                    <li>Erythroderma (>90% skin involvement)</li>
                                    <li>Generalized pustular psoriasis</li>
                                    <li>Severe drug eruptions (SJS/TEN)</li>
                                    <li>Eczema herpeticum (HSV infection)</li>
                                    <li>Angioedema with airway compromise</li>
                                    <li>Severe systemic symptoms</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Diagnosis Card -->
            <div class="step-card diagnosis fade-in">
                <div class="card-header" onclick="toggleCard(this)">
                    <div class="card-icon">üîç</div>
                    <div class="card-title">
                        <h2>Diagnosis</h2>
                        <p>Differentiate common inflamed skin conditions</p>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-body">
                        <div class="severity-indicators">
                            <div class="severity-item">
                                <div class="severity-dot red"></div>
                                <span>Urgent Referral</span>
                            </div>
                            <div class="severity-item">
                                <div class="severity-dot amber"></div>
                                <span>Caution/Investigate</span>
                            </div>
                            <div class="severity-item">
                                <div class="severity-dot green"></div>
                                <span>Primary Care Manage</span>
                            </div>
                        </div>

                        <div class="conditions-grid">
                            <div class="condition-card">
                                <h4>üå°Ô∏è Atopic Eczema <span class="badge stable">PC Manage</span></h4>
                                <p><strong>Criteria:</strong> Pruritus + erythema + excoriations + lichenification</p>
                                <p><strong>Distribution:</strong> Flexures (antecubital/popliteal fossa) in adults</p>
                                <p><strong>Key Features:</strong> Chronic relapsing course, personal/family atopy</p>
                                <p><strong>Comorbidities:</strong> Asthma, allergic rhinitis, infection risk</p>
                            </div>

                            <div class="condition-card">
                                <h4>‚ò†Ô∏è Contact Dermatitis <span class="badge caution">Caution</span></h4>
                                <p><strong>Irritant:</strong> Burning sensation, hands most common (wet work)</p>
                                <p><strong>Allergic:</strong> Type IV delayed hypersensitivity</p>
                                <p><strong>Common Allergens:</strong> Nickel, fragrances, preservatives, rubber</p>
                                <p><strong>Occupations:</strong> Healthcare workers, hairdressers, cleaners</p>
                            </div>

                            <div class="condition-card">
                                <h4>üß¥ Seborrheic Dermatitis <span class="badge stable">PC Manage</span></h4>
                                <p><strong>Distribution:</strong> Scalp, eyebrows, glabella, nasolabial folds, chest</p>
                                <p><strong>Appearance:</strong> Erythema with greasy yellow scale</p>
                                <p><strong>Pathophysiology:</strong> Yeast-driven (Malassezia)</p>
                                <p><strong>Often Asymptomatic:</strong> Mild itch or irritation</p>
                            </div>

                            <div class="condition-card">
                                <h4>üî¥ Psoriasis <span class="badge stable">PC Manage</span></h4>
                                <p><strong>Appearance:</strong> Well-demarcated plaques with silvery scale</p>
                                <p><strong>Auspitz Sign:</strong> Pinpoint bleeding after scale removal</p>
                                <p><strong>Koebner Phenomenon:</strong> Trauma-induced lesions</p>
                                <p><strong>Types:</strong> Chronic plaque (most common), guttate, inverse, pustular</p>
                                <p><strong>Comorbidities:</strong> CV risk, metabolic syndrome, psoriatic arthritis</p>
                            </div>

                            <div class="condition-card">
                                <h4>üéØ Urticaria & Angioedema <span class="badge caution">Caution</span></h4>
                                <p><strong>Acute:</strong> < 6 weeks duration</p>
                                <p><strong>Chronic:</strong> > 6 weeks (CSU - Chronic Spontaneous Urticaria)</p>
                                <p><strong>Pathophysiology:</strong> Mast cell degranulation ‚Üí histamine release</p>
                                <p><strong>Angioedema:</strong> Deep dermal edema (eyelids, lips, tongue, pharynx)</p>
                                <p><strong>‚ö†Ô∏è Airway involvement = EMERGENCY</strong></p>
                            </div>

                            <div class="condition-card">
                                <h4>ü¶† Tinea Infections <span class="badge caution">Caution</span></h4>
                                <p><strong>Tinea Corporis:</strong> Body ringworm, annular lesions</p>
                                <p><strong>Tinea Incognito:</strong> Modified by topical steroids</p>
                                <p><strong>Tinea Capitis:</strong> Scalp infection, requires systemic therapy</p>
                                <p><strong>Onychomycosis:</strong> Nail infection, often resistant to topicals</p>
                            </div>

                            <div class="condition-card">
                                <h4>üêõ Scabies <span class="badge caution">Caution</span></h4>
                                <p><strong>Key Symptom:</strong> Intense nocturnal pruritus</p>
                                <p><strong>Burrows:</strong> Web spaces, wrists, ankles, genitals, nipples</p>
                                <p><strong>‚ö†Ô∏è Highly contagious:</strong> Treat contacts & decontaminate environment</p>
                                <p><strong>Norwegian Scabies:</strong> Crusted, hyperkeratotic (immunocompromised)</p>
                            </div>

                            <div class="condition-card">
                                <h4>üî¨ Other Differentials <span class="badge caution">Caution</span></h4>
                                <p><strong>Cutaneous T-cell Lymphoma:</strong> If not responding to treatment</p>
                                <p><strong>Pityriasis Rosea:</strong> Herald patch ‚Üí Christmas tree distribution</p>
                                <p><strong>Dermatitis Herpetiformis:</strong> Pruritic papulovesicles, associated with coeliac</p>
                                <p><strong>Lichen Planus:</strong> Violaceous, polygonal papules</p>
                            </div>
                        </div>

                        <div class="important-note">
                            <h5>üéØ Key Diagnostic Principle</h5>
                            <p>If condition not responding to appropriate therapy after 6-8 months (or sooner if worsening), reconsider diagnosis and have low threshold for biopsy to rule out cutaneous T-cell lymphoma.</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Treatment Card -->
            <div class="step-card treatment fade-in">
                <div class="card-header" onclick="toggleCard(this)">
                    <div class="card-icon">üíä</div>
                    <div class="card-title">
                        <h2>Treatment</h2>
                        <p>Evidence-based management strategies</p>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-body">
                        <div class="section">
                            <h3><span class="section-icon">üõ°Ô∏è</span>General Principles - All Conditions</h3>
                            <div class="treatment-step">
                                <h5>1. Emollient Therapy</h5>
                                <ul>
                                    <li>Paraffin-based ointments as baseline (e.g., 50:50 white soft paraffin/liquid paraffin)</li>
                                    <li>Apply liberally and frequently (4-6 times daily)</li>
                                    <li>Use soap substitutes for washing</li>
                                    <li>Continue even when skin clear</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>2. Trigger Identification & Avoidance</h5>
                                <ul>
                                    <li>Wool, synthetic fibers, fragrances</li>
                                    <li>Excessive sweating, heat</li>
                                    <li>Psychological stressors</li>
                                    <li>Irritant avoidance (detergents, solvents)</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>3. Patient Education</h5>
                                <ul>
                                    <li><strong>Fingertip Unit (FTU):</strong> Amount for application</li>
                                    <li>How to step-down treatment</li>
                                    <li>When to seek medical review</li>
                                    <li>Expectations for chronic conditions</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üåø</span>Eczema Management</h3>
                            <div class="treatment-step">
                                <h5>Step 1: Topical Corticosteroids</h5>
                                <ul>
                                    <li><strong>Mild (1% hydrocortisone):</strong> Face, flexures, genitals</li>
                                    <li><strong>Moderate (clobetasone butyrate):</strong> Trunk, limbs</li>
                                    <li><strong>Potent (betamethasone valerate):</strong> Thicker plaques, palms/soles</li>
                                    <li><strong>Very Potent (clobetasol propionate):</strong> Short courses only, severe flares</li>
                                    <li>Apply once daily to active lesions until controlled (1-2 weeks)</li>
                                    <li>Then reduce frequency (alternate days ‚Üí weekends)</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Step 2: Topical Calcineurin Inhibitors</h5>
                                <ul>
                                    <li><strong>Tacrolimus 0.1% (adults):</strong> Face, neck, flexures</li>
                                    <li><strong>Tacrolimus 0.03% (children <5y):</strong></li>
                                    <li><strong>Pimecrolimus:</strong> Milder, less irritating</li>
                                    <li>Steroid-sparing agents, safe for long-term use</li>
                                    <li>Common: transient burning/stinging initially</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Step 3: Advanced Therapies</h5>
                                <ul>
                                    <li><strong>Wet Wraps:</strong> For moderate-severe flares</li>
                                    <li><strong>Antihistamines:</strong> For itch (sedating at night)</li>
                                    <li><strong>Phototherapy:</strong> Narrowband UVB</li>
                                    <li><strong>Systemic:</strong> Cyclosporine, methotrexate, azathioprine</li>
                                    <li><strong>Biologics:</strong> Dupilumab, tralokinumab (refractory cases)</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üßº</span>Seborrheic Dermatitis</h3>
                            <div class="treatment-step">
                                <h5>Scalp Treatment</h5>
                                <ul>
                                    <li><strong>Anti-fungal Shampoo:</strong> Ketoconazole 2% twice weekly</li>
                                    <li><strong>Alternative:</strong> Selenium sulfide, zinc pyrithione</li>
                                    <li><strong>Steroid Solutions:</strong> Betamethasone for inflammation (short course)</li>
                                    <li><strong>Keratolytics:</strong> Salicylic acid, coal tar preparations</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Facial/Body Treatment</h5>
                                <ul>
                                    <li><strong>Ketoconazole 2% Cream:</strong> Daily application</li>
                                    <li><strong>Low-potency Steroids:</strong> Hydrocortisone 1% for inflammation</li>
                                    <li><strong>Topical Calcineurin Inhibitors:</strong> For maintenance</li>
                                    <li><strong>Chronic Management:</strong> Weekly anti-fungal shampoo for prevention</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üéØ</span>Psoriasis Management</h3>
                            <div class="treatment-step">
                                <h5>Topical Therapies</h5>
                                <ul>
                                    <li><strong>Vitamin D Analogs:</strong> Calcipotriol, calcitriol</li>
                                    <li><strong>Combined Steroid + Vitamin D:</strong> Dovobet/Daivobet gel/cream</li>
                                    <li><strong>Scalp:</strong> Keratolytics (salicylic acid), coconut oil for scale removal</li>
                                    <li><strong>Nails:</strong> Calcipotriol solution</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Escalation Pathway</h5>
                                <ul>
                                    <li><strong>Phototherapy:</strong> Narrowband UVB (failed topicals)</li>
                                    <li><strong>Systemic:</strong> Methotrexate, cyclosporine, acitretin</li>
                                    <li><strong>Biologics:</strong> Anti-TNF, IL-17, IL-23 inhibitors</li>
                                    <li><strong>Acitretin:</strong> Teratogenic (avoid pregnancy 2-3 years)</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">ü¶†</span>Infections & Infestations</h3>
                            <div class="treatment-step">
                                <h5>Bacterial Folliculitis</h5>
                                <ul>
                                    <li><strong>Topical:</strong> Antiseptic washes (chlorhexidine, benzoyl peroxide)</li>
                                    <li><strong>Systemic:</strong> Flucloxacillin (if widespread)</li>
                                    <li><strong>Prevention:</strong> Avoid occlusion, friction</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Tinea Infections</h5>
                                <ul>
                                    <li><strong>Corporis/Cruris:</strong> Terbinafine 1% cream BD for 1-2 weeks</li>
                                    <li><strong>Resistant:</strong> Oral terbinafine 250mg daily (monitor LFTs)</li>
                                    <li><strong>Capitis:</strong> Griseofulvin (licensed), or terbinafine/itraconazole</li>
                                    <li><strong>Treat Contacts:</strong> Especially for tinea capitis (Microsporum)</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Scabies <span class="badge urgent">HIGHLY CONTAGIOUS</span></h5>
                                <ul>
                                    <li><strong>First-line:</strong> Permethrin 5% cream</li>
                                    <li><strong>Application:</strong> Whole body (day 1 & day 7)</li>
                                    <li><strong>Contacts:</strong> Treat all household members simultaneously</li>
                                    <li><strong>Environment:</strong> Wash bedding/clothing >50¬∞C</li>
                                    <li><strong>Post-scabetic itch:</strong> Can persist 2-6 weeks (not treatment failure)</li>
                                    <li><strong>Resistant/Norwegian:</strong> Oral ivermectin 200mcg/kg</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üíâ</span>Urticaria & Angioedema</h3>
                            <div class="treatment-step">
                                <h5>First-line: Non-sedating Antihistamines</h5>
                                <ul>
                                    <li>Cetirizine 10mg daily, loratadine 10mg daily, fexofenadine 180mg daily</li>
                                    <li>Can increase dose up to 4x standard (under guidance)</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Short Courses (Severe Flares)</h5>
                                <ul>
                                    <li>Oral corticosteroids 0.5mg/kg (0.75mg/kg if inadequate response)</li>
                                    <li>Maximum 3-5 days to avoid rebound</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Refractory Chronic Urticaria</h5>
                                <ul>
                                    <li><strong>Omalizumab:</strong> Anti-IgE monoclonal antibody</li>
                                    <li><strong>Cyclosporine:</strong> Safe in pregnancy (unlike omalizumab)</li>
                                </ul>
                            </div>
                        </div>

                        <div class="referral-criteria">
                            <h4>üî∫ When to Escalate to Secondary Care</h4>
                            <ul style="margin-left: 20px; color: #856404;">
                                <li>Failure to respond to appropriate topical therapy after 6-8 weeks</li>
                                <li>Severe/widespread disease requiring phototherapy or systemic therapy</li>
                                <li>Diagnostic uncertainty (consider biopsy)</li>
                                <li>Severe infections requiring specialist management</li>
                                <li>Pregnancy with severe disease (needs specialist input)</li>
                                <li>Before initiating biologics or systemic immunosuppressants</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Follow-up Card -->
            <div class="step-card followup fade-in">
                <div class="card-header" onclick="toggleCard(this)">
                    <div class="card-icon">üìÖ</div>
                    <div class="card-title">
                        <h2>Follow-up & Referral</h2>
                        <p>Monitoring, maintenance, and when to refer</p>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content">
                    <div class="card-body">
                        <div class="section">
                            <h3><span class="section-icon">üìä</span>Assessment Scoring Systems</h3>
                            <div class="conditions-grid">
                                <div class="condition-card">
                                    <h4>Eczema Severity</h4>
                                    <p><strong>EASI Score:</strong> Eczema Area and Severity Index</p>
                                    <p><strong>Categories:</strong> Mild | Moderate | Severe</p>
                                    <p><strong>DLQI:</strong> Dermatology Life Quality Index</p>
                                </div>
                                <div class="condition-card">
                                    <h4>Psoriasis Severity</h4>
                                    <p><strong>PASI Score:</strong> Psoriasis Area and Severity Index</p>
                                    <p><strong>BSA:</strong> Body Surface Area involvement</p>
                                    <p><strong>PGA:</strong> Physician Global Assessment</p>
                                </div>
                                <div class="condition-card">
                                    <h4>Psoriatic Arthritis</h4>
                                    <p><strong>PEST Score:</strong> ‚â•2 = refer to rheumatology</p>
                                    <p>Ask about joint pain, nail changes, heel pain</p>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üîÑ</span>Follow-up Schedule</h3>
                            <div class="treatment-step">
                                <h5>Acute Flares</h5>
                                <ul>
                                    <li>Review in 1-2 weeks to assess response</li>
                                    <li>Check compliance and technique</li>
                                    <li>Adjust potency based on response</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Maintenance Phase</h5>
                                <ul>
                                    <li>Review every 3-6 months for stable patients</li>
                                    <li>Annual review for chronic conditions</li>
                                    <li>Monitor for side effects of long-term therapy</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Trigger Review</h5>
                                <ul>
                                    <li>Annual medication review</li>
                                    <li>Occupational exposure assessment</li>
                                    <li>Psychosocial support evaluation</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üéØ</span>Referral Criteria <span class="badge urgent">URGENT</span></h3>
                            <div class="conditions-grid">
                                <div class="condition-card">
                                    <h4>üî¥ Immediate/Same Day</h4>
                                    <ul style="color: #dc3545;">
                                        <li>Erythroderma (>90% skin involvement)</li>
                                        <li>Generalized pustular psoriasis</li>
                                        <li>Eczema herpeticum (suspected HSV)</li>
                                        <li>Stevens-Johnson Syndrome/TEN</li>
                                        <li>Severe angioedema with airway compromise</li>
                                        <li>Septicemia from skin infection</li>
                                    </ul>
                                </div>
                                <div class="condition-card">
                                    <h4>üü° Urgent (<2 weeks)</h4>
                                    <ul style="color: #856404;">
                                        <li>Severe flare not responding to potent steroids</li>
                                        <li>Significant impact on quality of life</li>
                                        <li>Severe facial/genital involvement</li>
                                        <li>Diagnostic uncertainty (need biopsy)</li>
                                        <li>Suspected cutaneous T-cell lymphoma</li>
                                        <li>Severe scalp psoriasis</li>
                                    </ul>
                                </div>
                                <div class="condition-card">
                                    <h4>üü¢ Routine (6-12 weeks)</h4>
                                    <ul style="color: #28a745;">
                                        <li>Failure to respond to appropriate therapy</li>
                                        <li>Persistent disease despite optimal primary care</li>
                                        <li>Consideration for systemic therapy/phototherapy</li>
                                        <li>Need for patch testing (contact dermatitis)</li>
                                        <li>Moderate chronic stable disease</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üé®</span>Skin of Color Considerations</h3>
                            <div class="important-note">
                                <h5>Key Differences in Presentation</h5>
                                <ul style="margin-left: 20px; color: #0c5460;">
                                    <li><strong>Erythema:</strong> May appear as purplish-dark tinge or grey</li>
                                    <li><strong>Post-inflammatory Hyperpigmentation:</strong> Very common, takes months-years to fade</li>
                                    <li><strong>Psoriasis:</strong> Silvery-white scale more prominent</li>
                                    <li><strong>Follicular Disorders:</strong> Pseudofolliculitis barbae common in black men</li>
                                    <li><strong>Corticosteroid Caution:</strong> Higher risk of pigment changes</li>
                                </ul>
                            </div>
                            <div class="treatment-step">
                                <h5>Management Adjustments</h5>
                                <ul>
                                    <li>Reassure about post-inflammatory pigmentation</li>
                                    <li>Avoid unnecessary high-potency steroids</li>
                                    <li>Consider earlier referral for cosmetic concerns</li>
                                    <li>Photograph documentation essential</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">ü§ù</span>Intermediate Care Services</h3>
                            <p>Before specialist referral, consider:</p>
                            <div class="treatment-step">
                                <h5>Primary Care Options</h5>
                                <ul>
                                    <li><strong>Clinical Pharmacist:</strong> Can provide detailed education on regimens</li>
                                    <li><strong>Consultant Connect:</strong> Same-day dermatology advice (if available)</li>
                                    <li><strong>Teledermatology:</strong> Photo-based advice services</li>
                                    <li><strong>GPwSI:</strong> GPs with Special Interest in dermatology</li>
                                </ul>
                            </div>
                        </div>

                        <div class="section">
                            <h3><span class="section-icon">üìã</span>Safety Monitoring</h3>
                            <div class="conditions-grid">
                                <div class="condition-card">
                                    <h4>Long-term Steroid Use</h4>
                                    <p>‚Ä¢ Skin atrophy</p>
                                    <p>‚Ä¢ Striae</p>
                                    <p>‚Ä¢ Telangiectasia</p>
                                    <p>‚Ä¢ Hypopigmentation</p>
                                    <p>‚Ä¢ Steroid-induced acne/rosacea</p>
                                </div>
                                <div class="condition-card">
                                    <h4>Systemic Therapy Baselines</h4>
                                    <p>‚Ä¢ FBC, U&E, LFTs, lipids</p>
                                    <p>‚Ä¢ Blood pressure (cyclosporine)</p>
                                    <p>‚Ä¢ Pregnancy test (teratogenic drugs)</p>
                                    <p>‚Ä¢ Vaccination status (biologics)</p>
                                    <p>‚Ä¢ TB screening (biologics)</p>
                                </div>
                            </div>
                        </div>

                        <div class="referral-criteria">
                            <h4>üìû When to Seek Immediate Advice</h4>
                            <ul style="margin-left: 20px; color: #856404;">
                                <li>Systemic symptoms (fever, malaise) with skin condition</li>
                                <li>Rapidly progressive disease</li>
                                <li>Severe pain disproportionate to appearance</li>
                                <li>Immunocompromised patients with severe manifestations</li>
                                <li>Pregnancy with severe skin disease</li>
                                <li>Children with severe or atypical presentations</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <script>
        function toggleCard(header) {
            const content = header.nextElementSibling;
            const icon = header.querySelector('.expand-icon');
            const isExpanded = content.classList.contains('expanded');
            
            // Close all other cards
            document.querySelectorAll('.card-content').forEach(card => {
                card.classList.remove('expanded');
            });
            document.querySelectorAll('.expand-icon').forEach(ic => {
                ic.style.transform = 'rotate(0deg)';
            });
            
            // Toggle current card
            if (!isExpanded) {
                content.classList.add('expanded');
                icon.style.transform = 'rotate(180deg)';
                
                // Update progress sidebar
                const step = header.closest('.step-card').id || header.closest('.step-card').classList[1];
                updateProgress(step);
                
                // Smooth scroll to card
                setTimeout(() => {
                    header.scrollIntoView({ behavior: 'smooth', block: 'start' });
                }, 100);
            }
        }

        function updateProgress(activeStep) {
            const progressItems = document.querySelectorAll('.progress-item');
            progressItems.forEach(item => {
                item.classList.remove('active', 'completed');
                const step = item.dataset.step;
                
                const stepOrder = ['assessment', 'diagnosis', 'treatment', 'followup'];
                const activeIndex = stepOrder.indexOf(activeStep);
                const itemIndex = stepOrder.indexOf(step);
                
                if (itemIndex < activeIndex) {
                    item.classList.add('completed');
                } else if (itemIndex === activeIndex) {
                    item.classList.add('active');
                }
            });
        }

        // Auto-expand assessment card on load
        document.addEventListener('DOMContentLoaded', function() {
            setTimeout(() => {
                const assessmentCard = document.querySelector('.assessment .card-header');
                if (assessmentCard) {
                    assessmentCard.click();
                }
            }, 500);
        });

        // Progress sidebar click handlers
        document.querySelectorAll('.progress-item').forEach(item => {
            item.addEventListener('click', function() {
                const step = this.dataset.step;
                const targetCard = document.querySelector(`.${step}`);
                if (targetCard) {
                    const header = targetCard.querySelector('.card-header');
                    header.click();
                    setTimeout(() => {
                        targetCard.scrollIntoView({ behavior: 'smooth', block: 'start' });
                    }, 100);
                }
            });
        });

        // Add fade-in animation on scroll
        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.classList.add('fade-in');
                }
            });
        }, { threshold: 0.1 });

        document.querySelectorAll('.step-card').forEach(card => {
            observer.observe(card);
        });
    </script>
</body>
</html>